Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo

Cancer Gene Therapy

Volumn 20, Issue 8, 2013, Pages 453-460

  Xu, C M ^a   Liu, W W ^a   Liu, C J ^a   Wen, C ^a   Lu, H F ^a   Wan, F S ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

apoptosis; mammalian STE20 like kinase 1; non small cell lung cancer; nude mice; transplanted tumor; yes associated protein

Indexed keywords

AMPHIREGULIN; ANTINEOPLASTIC AGENT; CISPLATIN; CONNECTIVE TISSUE GROWTH FACTOR; MAMMALIAN STE20 LIKE KINASE 1; MESSENGER RNA; PROTEIN KINASE; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EXPRESSION VECTOR; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR VOLUME; TUMOR XENOGRAFT;

EUKARYOTA; MAMMALIA; MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; GENE TRANSFER TECHNIQUES; GLYCOPROTEINS; HETEROGRAFTS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84882453371     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2013.40     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009; 59: 27-41.
3. Travis WD, Colby TV, Corrin B, Shumosato Y, Brambilla E. Histological Typing of Lungand Pleural Tumors. 3rd edn. Springer-Verlag
4. Chan DC, Earle KA, Zhao TL, Helfrich B, Zeng C, Baron A et al. Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors. Clin Cancer Res 2002; 8: 904-912.
5. Poulsen TT, Pedersen N, Poulsen HS. Replacement and suicide gene therapy for targeted treatment of lung cancer. Clin Lung Cancer 2005; 6: 227-236.
6. Alamgeer M, Ganju V, Neil Watkins D. Novel therapeutic targets in non-small cell lung cancer. Curr Opin Pharmacol 2013; 13: 394-401.
7. West L, Vidwans SJ, Campbell NP, Shrager J, Simon GR, Bueno R et al. A novel classification of lung cancer into molecular subtypes. PLoS One 2012; 7: e31906.
8. Ling P, Lu TJ, Yuan CJ, Lai MD. Biosignaling of mammalian Ste20-related kinases. Cell Signal 2008; 20: 1237-1247.
9. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16: 425-438.
10. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010; 107: 1431-1436.
11. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010; 107: 1437-1442.
12. Steinmann KSA, Schagdarsurengin U, Dammann RH. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 2009; 22: 1519-1526.
13. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR et al. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol 2007; 20: 331-338.
14. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 2011; 108: E1312-E1320.
15. Seidel C, Schagdarsurengin U, Blumke K, Wurl P, Pfeifer GP, Hauptmann S et al. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma. Mol Carcinog 2007; 46: 865-871.
16. Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 2005; 122: 421-434.
17. Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011; 138: 9-22.
18. Harvey K, Tapon N. The Salvador-Warts-Hippo pathway - an emerging tumoursuppressor network. Nat Rev Cancer 2007; 7: 182-191.
19. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 2006; 103: 12405-12410.
20. Zhang X, George J, Deb S, Degoutin JL, Takano EA, Fox SB et al. The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 2011; 30: 2810-2822.
21. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008; 39: 1582-1589.
22. Xu C, Liu C, Huang W, Tu S, Wan F. Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 268-279.
23. Ravet E, Lulka H, Gross F, Casteilla L, Buscail L, Cordelier P. Using lentiviral vectors for efficient pancreatic cancer gene therapy. Cancer Gene Ther 2010; 17: 315-324.
24. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M et al. Caspasemediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J 1998; 17: 2224-2234.
25. Morin-Kensicki EM, Boone BN, Howell M, Stonebraker JR, Teed J, Alb JG et al. Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65. Mol Cell Biol 2006; 26: 77-87.
26. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008; 22: 1962-1971.
27. Ng YK, Lau WS, Lui VW, Cheng AS, Ng PK, Tsui SK et al. Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells. FEBS Lett 2013; 587: 496-503.
28. Huang JM, Nagatomo I, Suzuki E, Mizuno T, Kumagai T, Berezov A et al. YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 2013; 32: 2220-2229.
29. Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009; 11: 1444-1450.
30. Liu AM, Xu MZ, Chen J, Poon RT, Luk JM. Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets 2010; 14: 855-868.
31. Oh S, Lee D, Kim T, Kim TS, Oh HJ, Hwang CY et al. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol 2009; 29: 6309-6320.
32. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130: 1120-1133.
33. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007; 17: 2054-2060.
34. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010; 19: 27-38.